Latest News and Press Releases

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...

Albion Enterprise VCT PLC (the “Company”)Director/PDMR Transaction Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated...

ALBION ENTERPRISE VCT PLC Issue of Equity and Total Voting Rights LEI Code 213800OVSRDHRJBMO720 Albion Enterprise VCT PLC (the “Company”) announces that on 27 March 2026 it allotted 10,558,674...

ALBION TECHNOLOGY & GENERAL VCT PLC Issue of Equity and Total Voting Rights LEI Code 213800TKJUY376H3KN16 Albion Technology & General VCT PLC (the “Company”) announces that on 27 March 2026...

ALBION CROWN VCT PLC Issue of Equity and Total Voting Rights LEI Code 213800SYIQPA3L3T1Q68 Albion Crown VCT PLC (the “Company”) announces that on 27 March 2026 it allotted 55,919,574 ordinary...

Oxford, UK – 27 March 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has been recognised with the ‘Most Innovative CDMO (Cell & Gene...

OCTOPUS APOLLO VCT PLC Issue of Equity and Total Voting Rights Octopus Apollo VCT plc (the ‘Company’) announces that 71,637,027 Ordinary Shares of 0.1p each (the ‘Shares’) were issued and allotted...